| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |